Journal article · 2021 · Open access

Stated Preferences in Non-Small-Cell Lung Cancer: A Discrete Choice Experiment

Isandra Oliveira Meirelles, Carlos Alberto da Silva Magliano

Patient Preference and Adherence, Volume 15, 911–917 · Published 1 April 2021 · DOI 10.2147/ppa.s302394

Open PDFView at the publisherCite this paper

In brief

“Stated Preferences in Non-Small-Cell Lung Cancer: A Discrete Choice Experiment” is a 2021 journal article by Isandra Oliveira Meirelles and Carlos Alberto da Silva Magliano, published in Patient Preference and Adherence. OpenAlex counts 15 citations as of 22 November 2026. It is open access under a CC BY-NC licence: the full text is free to read at Patient Preference and Adherence.

Citations
15
Most cited in
2025 (9)
Field-weighted impact
0.45
References
14
Authors
2

Abstract

INTRODUCTION: The different alternatives for non-small-cell lung cancer (NSCLC) treatment can increase survival but cause important adverse events. Therefore, patients' preference can play a critical role in decision-making. Among stated preference methods, discrete choice experiment (DCE) is the most applied in health care to elicit preferences. This research aims to elicit patients' preference evaluating the trade-off between the risks (adverse events) and benefits (survival) of systemic treatments, from the perspective of Brazilian patients with locally advanced, metastatic or recurrent NSCLC. METHODS: A DCE was performed following the steps of attributes selection; construction of tasks and respondents' preference elicitation. Patients chose between 2 hypothetical treatments described by the attributes tiredness, hair loss, skin rash, hospitalization, administration mode and survival. A paper-and-pencil survey method was used to elicit the answers from the participants. The statistical data analysis used a mixed logit model to predict the relative importance of the attributes. RESULTS: Most of the 65 patients interviewed were men (53.8%), mean age of 65 (95% confidence interval [CI]: 63-67) years and lung cancer stage IV (67.7%). Except for hospitalization and administration mode, the attributes coefficients were statistically significant (p < 0.005) for patients' preferences. Patients would require a minimum survival gain of 11.72 (CI: 10.28-4.22) months and 19.72 (CI: 17.31-7.09) months to accept a treatment that causes severe tiredness and severe skin rash, respectively. The market share of the treatments was calculated according to the DCE aggregate-level estimation, considering the impact of each treatment's side effects. Paclitaxel plus carboplatin had an estimated market share of 31%, followed by gefitinib (27%), erlotinib (24%) and docetaxel (18%). CONCLUSION: In general, less than a year of survival gain would not suffice for the appearance of severe skin rash or tiredness.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Meirelles, I. O., & Magliano, C. A. D. S. (2021). Stated Preferences in Non-Small-Cell Lung Cancer: A Discrete Choice Experiment. Patient Preference and Adherence, Volume 15, 911–917. https://doi.org/10.2147/ppa.s302394

MLA 9

Meirelles, Isandra Oliveira, and Carlos Alberto da Silva Magliano. “Stated Preferences in Non-Small-Cell Lung Cancer: A Discrete Choice Experiment.” Patient Preference and Adherence, vol. Volume 15, 2021, pp. 911–917. https://doi.org/10.2147/ppa.s302394.

Chicago

Meirelles, Isandra Oliveira and Carlos Alberto da Silva Magliano. 2021. “Stated Preferences in Non-Small-Cell Lung Cancer: A Discrete Choice Experiment.” Patient Preference and Adherence Volume 15: 911–917. https://doi.org/10.2147/ppa.s302394.

Harvard

Meirelles, I. O. and Magliano, C. A. D. S. (2021) ‘Stated Preferences in Non-Small-Cell Lung Cancer: A Discrete Choice Experiment’, Patient Preference and Adherence, Volume 15, pp. 911–917. doi:10.2147/ppa.s302394.

IEEE

I. O. Meirelles and C. A. D. S. Magliano, “Stated Preferences in Non-Small-Cell Lung Cancer: A Discrete Choice Experiment,” Patient Preference and Adherence, vol. Volume 15, pp. 911–917, 2021, doi: 10.2147/ppa.s302394.

BibTeX

@article{meirelles2021stated,
  title     = {{Stated Preferences in Non-Small-Cell Lung Cancer: A Discrete Choice Experiment}},
  author    = {Meirelles, Isandra Oliveira and Magliano, Carlos Alberto da Silva},
  journal   = {Patient Preference and Adherence},
  year      = {2021},
  volume    = {Volume 15},
  pages     = {911--917},
  doi       = {10.2147/ppa.s302394},
  url       = {https://doi.org/10.2147/ppa.s302394}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
202211
202311
202411
202599
202633

Its field-weighted citation impact is 0.45: it has been cited 0.45 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Economic and Environmental Valuation

  • non-small cell lung cancer
  • patient preferences
  • treatment trade-offs
  • adverse events
  • survival benefit
  • systemic cancer therapy
  • treatment side effects
  • fatigue

Work with this paper

Most-cited papers in Economics, Econometrics and Finance

All highly cited Economics, Econometrics and Finance papers

Questions about this paper

How do I cite this paper in APA style?

Meirelles, I. O., & Magliano, C. A. D. S. (2021). Stated Preferences in Non-Small-Cell Lung Cancer: A Discrete Choice Experiment. Patient Preference and Adherence, Volume 15, 911–917. https://doi.org/10.2147/ppa.s302394

How many times has this paper been cited?

15 times, according to OpenAlex on 22 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Patient Preference and Adherence: sign in and open the PDF from this page.

Who wrote this paper?

Isandra Oliveira Meirelles, Carlos Alberto da Silva Magliano.

What is the DOI of this paper?

10.2147/ppa.s302394, permanently at https://doi.org/10.2147/ppa.s302394. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 22 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.